The DCGI has warned pharma associations of strict action against the practice of extending a primary brand name to treat a completely different illness.
3 min read15 Jul 2026The initiative aims to resolve discrepancies in the Central Drugs Standard Control Organisation’s database and create a comprehensive repository of missing drug approvals over the past 81 years, including legacy licences dating back to 1945 when India’s drug laws were first enacted.
5 min read3 Jul 2026A major-cleanup of the use of toxic chemicals in drug making and testing is on the way, with the IPC under health ministry preparing new standards. The move aims to reduce the use of carcinogenic substances, and reduce energy intensity in the pharmaceutical industry.
4 min read18 May 2026Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug development.
4 min read3 May 2026The CDSCO asks states to also strengthen the necessary infrastructure, including the provision of adequate manpower under the State Health Regulatory Excellence Index (SHRESTH)
2 min read20 Apr 2026Critical sectors, from pharma to steel, will get up to 70% of their pre-March consumption as government eases allocations after earlier import disruptions.
2 min read8 Apr 2026India is betting ₹13,000 crore to move beyond generics into high-value biologics and advanced chemicals. Here’s how it plans to build talent, ensure safety and tap a $300 billion global opportunity.
2 min read24 Mar 2026It is changing the way drugs are discovered and tested
3 min read11 Mar 2026It will transform how medicines are created—and the industry itself
7 min read10 Mar 2026After struggling through the 1990s, Desh Bandhu Gupta, founder of pharma company Lupin, set out a clear strategy for growth that would outlast him
5 min read16 Feb 2026Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.